Volume 7, Issue 3 pp. 155-161
ORIGINAL ARTICLE

Noradrenergic Mechanisms Controlling Urethral Smooth and Striated Muscle Function in Urethral Continence Reflex in Rats

Akira FURUTA

Corresponding Author

Akira FURUTA

Department of Urology, Jikei University School of Medicine, Tokyo, Japan

Correspondence: Akira Furuta, MD, PhD, 3-25-8 Nishi-shinbashi Minato-ku, Tokyo 105-8461, Japan. Tel: +81-3-3433-1111; Fax: +81-3-3437-2389. Email: [email protected]Search for more papers by this author
Yasuyuki SUZUKI

Yasuyuki SUZUKI

Department of Urology, Tokyo Rehabilitation Hospital, Tokyo, Japan

Search for more papers by this author
Shouji KIMURA

Shouji KIMURA

Department of Urology, Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Kouji ASANO

Kouji ASANO

Department of Urology, Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Shin EGAWA

Shin EGAWA

Department of Urology, Jikei University School of Medicine, Tokyo, Japan

Search for more papers by this author
Naoki YOSHIMURA

Naoki YOSHIMURA

Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

Search for more papers by this author
First published: 07 July 2014
Citations: 3

Abstract

Objectives

To investigate the role of noradrenergic pathways in the urethral continence reflex during abdominal compression in rats.

Methods

Under urethane anesthesia, urethral baseline pressure (UBP) and urethral pressure response (UPR) during momentary abdominal compression using a 100 g weight was measured using a transurethral microtransducer-tipped catheter placed at the middle urethra in Sprague–Dawley female rats. Following intravenous (i.v.) application of hexamethonium or α-bungarotoxin to block urethral smooth or striated muscle function, respectively, the effects of terazosin, an α1-adrenoceptor (AR) antagonist (0.3 mg/kg, i.v.), medetomidine, an α2-AR agonist (0.3 mg/kg, i.v.) or nisoxetine, a norepinephrine reuptake inhibitor (1 mg/kg, i.v.) followed by terazosin on UBP and UPR were examined.

Results

After hexamethonium pretreatment, terazosin did not alter UBP or UPR, whereas medetomidine significantly decreased UPR by 28% without UBP changes. Nisoxetine significantly increased UPR by 64%, which was eliminated by terazosin, but UBP was not altered by nisoxetine. After α-bungarotoxin pretreatment, UBP and UPR were significantly decreased by terazosin or medetomidine. Nisoxetine induced significant increases in UBP and UPR by 16 and 15%, respectively, which were antagonized by terazosin.

Conclusion

These results suggest that: the baseline activity and reflex contraction of urethral smooth muscle are decreased by α1-AR inhibition or α2-AR stimulation; the reflex contraction of urethral striated muscle is decreased by α2-AR stimulation, but not by α1-AR inhibition; and nisoxetine increases baseline and reflex activity of smooth muscle in addition to striated muscle reflex activity by α1-AR stimulation. These findings will be useful to understand nerve-mediated urethral closure mechanisms.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.